Abacavir is a nucleoside reverse transcriptase inhibitor used as part of combination therapy to manage HIV infection.
Abacavir is a medication that belongs to the class of nucleoside reverse-transcriptase inhibitors (NRTIs). It is designed to interfere with the replication of the human immunodeficiency virus type 1 (HIV-1). By blocking a key step in the virus’s life cycle, abacavir helps to keep the amount of virus in the body low, supporting overall immune health. This active ingredient is found in several combination products, most notably the tablet Triumeq.
Abacavir is incorporated into a range of formulations, the most common being the fixed-dose combination tablet Triumeq. Triumeq contains abacavir together with lamivudine and dolutegravir, offering a single-pill regimen once daily. In Hong Kong, Triumeq is listed on the Pharmacy and Poisons Ordinance as a prescription medicine and is supplied through hospitals, the Hospital Authority and accredited community pharmacies. The tablet is available in 600 mg/300 mg/50 mg strengths for each component, allowing patients to receive three antiretroviral agents in one dose. While generic versions of abacavir alone exist, Triumeq remains the primary brand that includes abacavir as part of a combined HIV-treatment regimen in the local market.
These uses are approved by the Hong Kong Department of Health and align with international guidelines for antiretroviral therapy.
Abacavir mimics a natural building block of viral DNA. When HIV-1 tries to copy its genetic material, the drug is incorporated into the growing chain and stops further extension. This interruption prevents the virus from producing new infectious particles, allowing the body’s immune cells to recover and function more effectively. The antiviral effect typically begins within a few days of regular use, although full viral suppression may take several weeks of consistent treatment.
These symptoms are usually transient and resolve without medical intervention. Adjustments in diet or timing of the tablet may help reduce discomfort.
If any of these signs appear, immediate medical attention is required.
For a complete list of possible drug-food or drug-drug interactions, refer to the individual medication’s information page.
Keep abacavir-containing tablets in their original packaging, stored at room temperature away from moisture and direct sunlight. The typical treatment course for HIV infection is long-term, often continuing for many years, but the exact duration depends on the specific medication and the patient’s health status. Always follow the instructions printed on the product label and the guidance provided with each prescribed medicine. For detailed usage, dosing, and administration, refer to your specific medication’s information.
This article offers general educational information about abacavir as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing abacavir may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
